LTM Expands BlueVerse™ Tech with AppIQ, AgentIQ, and FusionIQ to Accelerate AI-Led Engineering
Mumbai, India & Warren, N.J., March 23, 2026 – LTM, a Larsen & Toubro Group Company and a technology services company, today announced the expansion of BlueVerse™ Tech, its AI-led engineering platform, with the launch of AppIQ, AgentIQ, and FusionIQ. These platforms are designed to help enterprises modernize applications, orchestrate AI-first software delivery, and engineer quality at scale.AppIQ utilizes AI to understand legacy codebases, generate documentation, and produce actionable specifications for forward engineering, reducing modernization time and costs. AgentIQ provides a platform for deploying, governing, and orchestrating AI agents across the software delivery lifecycle. FusionIQ accelerates test automation by embedding AI-driven monitoring and feedback into testing workflows.
Together, AppIQ, AgentIQ, and FusionIQ are expected to deliver a 40-50% reduction in engineering effort across the software development lifecycle, accelerating time-to-market and lowering operational costs.
"BlueVerse™ Tech reflects a fundamental shift in how engineering organizations create value with AI," said Gururaj Deshpande, Chief Delivery Officer, LTM. “By embedding AI across modernization, delivery orchestration, and quality engineering, we are helping clients reduce complexity, improve predictability, and move faster with confidence.”
AppIQ, AgentIQ, and FusionIQ are available globally as part of LTM's BlueVerse™ Tech and AI-Led Engineering offerings. To learn more, visit www.ltm.com/blueverse.
LTM is a technology services company and the Business Creativity partner to the world's largest enterprises. With over 87,000 employees across 40 countries, LTM aims to help clients outperform and outcreate the market. Read more at LTM.com.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.